119 related articles for article (PubMed ID: 2141152)
1. [Immunogenetics of primary membranous glomerulonephritis].
Berthoux FC; Berthoux P; Hassan AA; Vacherot C; Pomier G; Laurent B; Le Petit JC
Presse Med; 1990 May; 19(21):990-3. PubMed ID: 2141152
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens; functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations.
Berthoux FC; Laurent B; le Petit JC; Genin C; Broutin F; Touraine F; Hassan AA; Champailler A
Clin Nephrol; 1984 Jul; 22(1):15-20. PubMed ID: 6236923
[TBL] [Abstract][Full Text] [Related]
3. Major-histocompatibility-complex extended haplotypes in membranoproliferative glomerulonephritis.
Welch TR; Beischel L; Balakrishnan K; Quinlan M; West CD
N Engl J Med; 1986 Jun; 314(23):1476-81. PubMed ID: 3458025
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics and immunopathology of human membranous glomerulonephritis.
Laurent B; Berthoux FC; Le Petit JC; Genin G; Laurent P; Broutin F; Touraine F; Touraine JL
Proc Eur Dial Transplant Assoc; 1983; 19():629-34. PubMed ID: 6410385
[TBL] [Abstract][Full Text] [Related]
5. Familial idiopathic membranous glomerulonephritis.
Vasmant D; Murnaghan K; Bensman A; Muller JY; Mougenot B
Int J Pediatr Nephrol; 1984 Dec; 5(4):193-6. PubMed ID: 6597809
[TBL] [Abstract][Full Text] [Related]
6. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.
Hiki Y; Kobayashi Y; Itoh I; Kashiwagi N
Kidney Int; 1984 Jun; 25(6):953-7. PubMed ID: 6332232
[TBL] [Abstract][Full Text] [Related]
7. 14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes.
Steenkiste A; Valdes AM; Feolo M; Hoffman D; Concannon P; Noble J; Schoch G; Hansen J; Helmberg W; Dorman JS; Thomson G; Pugliese A;
Tissue Antigens; 2007 Apr; 69 Suppl 1():214-25. PubMed ID: 17445204
[TBL] [Abstract][Full Text] [Related]
8. HLA-B8/DR3 phenotype and the primary immune response.
Kallenberg CG; Klaassen RJ; Beelen JM; The TH
Clin Immunol Immunopathol; 1985 Jan; 34(1):135-40. PubMed ID: 3871182
[TBL] [Abstract][Full Text] [Related]
9. [Polymorphism of C4 and factor B in type I diabetes].
Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
[TBL] [Abstract][Full Text] [Related]
10. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
11. Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese.
Tomura S; Kashiwabara H; Tuchida H; Shishido H; Sakurai S; Miyajima T; Tsuji K; Takeuchi J
Nephron; 1984; 36(4):242-5. PubMed ID: 6424039
[TBL] [Abstract][Full Text] [Related]
12. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
13. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype.
Kremer JM
J Rheumatol; 1986 Jun; 13(3):593-7. PubMed ID: 3488404
[TBL] [Abstract][Full Text] [Related]
14. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
15. Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR 3 and MT-2 without involvement of HLA-B 18 and no association to BfF1.
Müller GA; Müller C; Liebau G; Kömpf J; Ising H; Wernet P
Tissue Antigens; 1981 Mar; 17(3):332-7. PubMed ID: 7314067
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
18. Elevated natural killer cytotoxicity in HLA-B8 and HLA-DR3-positive individuals.
Jakobisiak M; Saidman S; Schlaut J; Pazderka F; Dossetor JB
Immunol Lett; 1986 Mar; 12(2-3):61-3. PubMed ID: 3087867
[TBL] [Abstract][Full Text] [Related]
19. HLA-A, B, DR and Bf allotypes in patients with idiopathic membranous nephropathy (IMN).
Papiha SS; Pareek SK; Rodger RS; Morley AR; Wilkinson R; Roberts DF; Kerr DN
Kidney Int; 1987 Jan; 31(1):130-4. PubMed ID: 3470555
[TBL] [Abstract][Full Text] [Related]
20. Association between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products.
Müller GA; Gebhardt M; Kömpf J; Baldwin WM; Ziegenhagen D; Bohle A
Kidney Int; 1984 Jan; 25(1):115-8. PubMed ID: 6233449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
